Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
107.82
(
0.33%
)
Bitcoin
76,951.88
(
-0.59%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: None

Thursday, 06/14/2012 8:54:56 AM

Thursday, June 14, 2012 8:54:56 AM

Post# of 257580
Teva's (TEVA +0.4%) Copaxone multiple sclerosis drug performed well vs. a placebo in a Phase III trial that assessed its effectiveness under a new dosage regime of 40mg three times a week rather than the usual 20mg a day schedule
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today